Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
14.01
-0.17 (-1.20%)
At close: Jun 26, 2026, 4:00 PM EDT
14.18
+0.17 (1.21%)
After-hours: Jun 26, 2026, 7:45 PM EDT
Summit Therapeutics Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for Summit Therapeutics stock have an average target of 29.56, with a low estimate of 7.70 and a high estimate of 45. The average target predicts an increase of 110.99% from the current stock price of 14.01.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Summit Therapeutics stock from 17 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 10 | 11 | 9 | 9 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 3 | 3 | 4 | 4 | 5 | 5 |
| Sell | 1 | 1 | 1 | 1 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 16 | 16 | 17 | 17 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold Maintains $18 | Hold | Maintains | $18 | +28.48% | Jun 2, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $45 | Buy | Maintains | $45 | +221.20% | Jun 1, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $40 | Buy | Maintains | $40 | +185.51% | Jun 1, 2026 |
| Citi | Citi | Buy Maintains $40 | Buy | Maintains | $40 | +185.51% | Jun 1, 2026 |
| Wells Fargo | Wells Fargo | Buy Reiterates $30 | Buy | Reiterates | $30 | +114.13% | Jun 1, 2026 |
Financial Forecast
Revenue This Year
3.23M
Revenue Next Year
55.48M
from 3.23M
Increased by 1,617.20%
EPS This Year
-1.09
from -1.41
EPS Next Year
-1.16
from -1.09
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 14.6M | 169.9M | |
| Avg | 3.2M | 55.5M | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | 5,156.9% | 3,124.9% |
| Avg | 1,617.2% | 917.5% |
| Low | -100.0% | -48.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.74 | -0.80 | |
| Avg | -1.09 | -1.16 | |
| Low | -1.56 | -1.61 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.